As a dedicated intellectual property firm, Frommer Lawrence & Haug LLP (“FLH”) offers clients seamless, superior representation that draws on the expertise of its more than 80 attorneys and scientific advisors. FLH excels at both preparing and trying high-stakes IP cases, as well as counseling clients in areas such as product life cycle management, due diligence, FDA/regulatory, FTC review, antitrust, and licensing.
“What differentiates us is our ability to integrate practice areas,” says founding and managing partner Ed Haug. “We can put everyone in one room with the client and provide comprehensive legal service that covers the whole life cycle of a patent.”
The firm also has one of the nation’s leading practices covering the Drug Price Competition and Patent Term Restoration Act, or “Hatch-Waxman” Act. “The loss of patent protection can reduce a company’s bottom line by billions,” notes partner Sandra Kuzmich, who leads FLH’s Life Sciences practice. “But our collaborative culture has helped in mastering Hatch-Waxman’s intricacies.”
The firm’s legal group includes 13 attorneys who are AV Preeminent® rated by Martindale-Hubbell® – a peer recognition that places them at the highest level of professional excellence. Many attorneys also have more than 30 years of experience in IP law, as well as advanced degrees in science and engineering. In addition, the firm has on-staff scientific advisors to assist in preparing patent applications and to provide counsel on regulatory issues and ongoing complex litigations.
“At FLH we have the right mix of scientific background, expertise, and litigation experience in patent law,” says partner Porter Fleming, who heads FLH’s Trial Advocacy Group. “From the bench chemist, to in-house counsel, to the CEO, we speak their language.”